Published in Lab Law Weekly, August 19th, 2005
According to Klaus May, Genomatix's head of sales and marketing, this contract covers preferred access for all researchers from the French National Genopoles Network to GenomatixSuitePE.
According to the company, GenomatixSuitePE enables biologists to discover, explore, and understand biologically relevant pathways down to the molecular level. Applying the GenomatixSuitePE pipeline to a researcher's set of genes, e.g., from a microarray analysis, generates the full biological network, allowing for functional analysis...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly